Trial Profile
A multicentre, observational clinical registry in HIV/HCV coinfected patients initiating Ledipasvir/Sofosbuvir
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 18 Apr 2018
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 18 Apr 2018 New trial record
- 07 Mar 2018 To date (7 Mar 2018), 171 patients has been enrolled in this trial.
- 07 Mar 2018 Interim results (n=9) presented at the 25th Conference on Retroviruses and Opportunistic Infections